 | | | | |
| |  | |  | | |
| |  |
| PRIME NEWS |  |
|
 |
|
|
AtCor Medical and SunTech Medical have formed a strategic alliance aimed at improving blood pressure measurement and overall cardiovascular health assessment and management
|
|
|
|
|
|
|
|
|
Eisai received approval from Japan's Ministry of Health, Labour and Welfare to market Lunesta (eszopiclone), a product the company has been developing in Japan, as a treatment for insomnia
|
|
|
|
|
|
|
 | | |
The latest pharmaceutical technology news, trends and analysis, pharma business and investment opportunities, pharmaceutical technology breakthroughs, launch and review of pharma, biopharma & pharmaceutical products, features, event listings and job postings.
| | | | |  | |  | | |
|
|
|
|
|
|
 |
|
 |
|
|
|
 |
FEATURES |
 |
|
|
|
Revolution in deriving blood protein
|
|
| Wuhan Healthgen has utilized the knowledge of expressing blood protein in an unconventional method and are conducting research and manufacturing services for expressing and producing proteins es utilizing the rice endosperm-specific expression |
|
|
|
|
|
Study shows cancer incidence rates on rise in Australia
|
|
| Over the past quarter century in Australia, cancer incidence rates have increased while deaths from cancer have steadily decreased. Those are some of the findings of a recent study published early online in the Asia-Pacific Journal of Clinical Oncolo |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS |
|
|
|
|
Annual heart care meet debates managing top killer
|
|
| Leading global and Asian experts in cardiovascular medicine and diabetes at the Asia Cardiocare Summit in Hong Kong this month called people in Asia to reduce their total risk of cardiovascular disease |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
NIH scientists find cause of rare immune disease
|
|
| Investigators at the National Institutes of Health have identified a genetic mutation in three unrelated families that causes a rare immune disorder characterized by excessive and impaired immune function |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
Amerigen, VIWA sign MoU to develop generic medicines for China
|
|
| Amerigen Pharmaceuticals and VIWA Pharmaceutical jointly announced the signing of a memorandum of understanding setting out their intention to establish a joint venture to develop and register a range of branded generic medicines for sale in China |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRENDS & ANALYSIS |
|
|
|
|
Pain market remains area of high unmet need: report
|
|
| According to a new Espicom report despite a plethora of medications, the pain market remains an area of high unmet need as current therapies are often less than effective and/or have undesirable side effects |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
